MTD:NYE-Mettler-Toledo International Inc (USD)

COMMON STOCK | Diagnostics & Research |

Last Closing

USD 1286.54

Change

-16.59 (-1.27)%

Market Cap

N/A

Volume

0.13M

Analyst Target

USD 865.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-21 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

+2.28 (+1.10%)

USD 148.68B
A Agilent Technologies Inc

-1.42 (-1.04%)

USD 43.23B
IQV IQVIA Holdings Inc

-2.97 (-1.53%)

USD 36.97B
LH Laboratory Corporation of Amer..

+0.68 (+0.27%)

USD 20.54B
DGX Quest Diagnostics Incorporated

+0.10 (+0.06%)

USD 18.67B
QGEN Qiagen NV

+1.00 (+2.59%)

USD 9.65B
CRL Charles River Laboratories

+0.77 (+0.47%)

USD 8.50B
VNRX Volitionrx Ltd

-0.03 (-5.17%)

USD 0.06B
ENZ Enzo Biochem Inc

-0.01 (-2.07%)

USD 0.03B
TMO Thermo Fisher Scientific Inc

-5.28 (-0.98%)

N/A

ETFs Containing MTD

MCSE Martin Currie Sustainable.. 5.12 % 0.00 %

-0.04 (-1.28%)

N/A
EPRE 4.58 % 0.00 %

N/A

N/A
ASRP:XETRA 2.39 % 0.00 %

N/A

N/A
XMLC:F 2.27 % 0.00 %

N/A

N/A
EMOT First Trust Exchange-Trad.. 2.11 % 0.00 %

-0.29 (-1.28%)

USD 4.38M
XLVE:CA 1.82 % 0.00 %

N/A

N/A
HECO SPDR Galaxy Hedged Digita.. 0.00 % 0.95 %

-2.31 (-1.28%)

N/A
IBB iShares Biotechnology ETF 0.00 % 0.47 %

-0.52 (-1.28%)

USD 6.39B
QRI:CA 0.00 % 1.06 %

N/A

N/A
YXM.B:CA 0.00 % 0.69 %

N/A

N/A
MJJ 0.00 % 0.00 %

N/A

N/A
MJO 0.00 % 0.00 %

N/A

N/A
DWEQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.14% 85% B 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.14% 85% B 75% C
Trailing 12 Months  
Capital Gain 6.34% 69% C- 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.34% 69% C- 43% F
Trailing 5 Years  
Capital Gain 69.23% 92% A 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 69.23% 92% A 76% C+
Average Annual (5 Year Horizon)  
Capital Gain 13.33% 77% C+ 71% C-
Dividend Return 13.33% 69% C- 66% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 28.89% 46% F 37% F
Risk Adjusted Return 46.15% 85% B 60% D-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.